TY  - JOUR 
AU  - González-Pelayo, Silvia
AU  - G. Salado, Irene
AU  - Zaldivar, Josefa
AU  - Sebastián Pérez, Víctor
AU  - Ligling, Li
AU  - Geiger, Larissa
AU  - Campillo E, Nuria
AU  - Gil, Carmem
AU  - V. Morales, Aida
AU  - Pérez, Ignacio
AU  - Mártinez, Ana
PY  - 2017
SN  - 0223-5234
UR  - http://hdl.handle.net/10366/154735
AB  - Leucine-rich repeat kinase 2 (LRRK2) is one of the most pursued targets for Parkinson's disease (PD) therapy. Moreover, it has recently described its role in regulating Wnt signaling and thus, it may be involved in adult neurogenesis. This new...
PB  - European Journal of Medicinal Chemistry
KW  - LRRK2 inhibitorsProtein kinase inhibitorsIndolinoneAdult neurogenesisNeural stem cellRegenerative medicine
TI  - Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents
ER  -